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Abstract
Background: Ankyrin repeats and LEM domain containing protein 1 (Ankle1) belongs to the LEM protein family,
whose members share a chromatin-interacting LEM motif. Unlike most other LEM proteins, Ankle1 is not an integral
protein of the inner nuclear membrane but shuttles between the nucleus and the cytoplasm. It contains a GIY-YIG-type
nuclease domain, but its function is unknown. The mammalian genome encodes only one other GIY-YIG domain
protein, termed Slx1. Slx1 has been described as a resolvase that processes Holliday junctions during homologous
recombination-mediated DNA double strand break repair. Resolvase activity is regulated in a spatial and temporal
manner during the cell cycle. We hypothesized that Ankle1 may have a similar function and its nucleo-cytoplasmic
shuttling may contribute to the regulation of Ankle1 activity. Hence, we aimed at identifying the domains mediating
Ankle1 shuttling and investigating whether cellular localization is affected during DNA damage response.
Results: Sequence analysis predicts the presence of two canonical nuclear import and export signals in Ankle1.
Immunofluorescence microscopy of cells expressing wild-type and various mutated Ankle1-fusion proteins revealed a
C-terminally located classical monopartite nuclear localization signal and a centrally located CRM1-dependent nuclear
export signal that mediate nucleo-cytoplasmic shuttling of Ankle1. These sequences are also functional in heterologous
proteins. The predominant localization of Ankle1 in the cytoplasm, however, does not change upon induction of
several DNA damage response pathways throughout the cell cycle.
Conclusions: We identified the domains mediating nuclear import and export of Ankle1. Ankle1’s cellular localization
was not affected following DNA damage.
Keywords: Ankle1, LEM protein, Nuclease, Resolvase, Nuclear transport, Nuclear export
Background
The LAP2-emerin-MAN1 (LEM) protein family com-
prises a group of inner nuclear membrane and nucleoplas-
mic proteins [1, 2] with important functions in various
cellular processes, including nuclear envelope architecture
[3], DNA replication [4], cell cycle control [5], chromatin
organization [6, 7] and the regulation of gene expression
and signaling pathways [8–11]. All proteins in this family
share the LEM domain, a ~40 amino acid long bi-helical
motif, which binds the conserved metazoan chromatin-
associated protein Barrier-to-Autointegration Factor
(BAF) [12–19]. Besides the LEM domain, different add-
itional motifs and functional domains are present in LEM
proteins, such as a transmembrane domain (in the LEM
proteins emerin, LEM2, MAN1, most LAP2 isoforms,
and LEMD1), a carboxy-terminal winged-helix domain
(present in LEM2 and MAN1), a LEM-like motif
(found in all isoforms of LAP2), and ankyrin repeats in
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Ankyrin Repeats and LEM-domain containing proteins
(Ankle) 1 and 2 [2, 14, 20–23].
Ankle1 has several unique features among the LEM
protein family members. It lacks a transmembrane do-
main and shuttles between the cytoplasm and the nu-
cleoplasm, and it contains a C-terminal GIY-YIG-type
endonuclease domain [22, 24]. The GIY-YIG domain is
the hallmark of a subgroup of the homing endonuclease
superfamily [25, 26], represented mostly by group I and
II introns, archaeal introns and inteins that catalyze their
transfer within genomes by introducing strand breaks in
intron- and intein-lacking sequences [25, 27, 28]. We
have previously shown that the GIY-YIG domain of
Ankle1 has nuclease catalytic activity that cuts plasmid
DNA in vitro and induces DNA damage in vivo [22, 24].
Based on the findings in C. elegans that an inactivating
mutation in the worm Ankle1 ortholog LEM3 leads to
hypersensitivity of the worm mutants to various types of
DNA damage, including ionizing radiation, UV-C light
and DNA crosslinking agents, Ankle1/LEM3 was pro-
posed to be involved in DNA damage repair pathways
[24]. Embryos from irradiated lem-3 mutant worms also
suffer from severe defects during cell division, such as
chromosome mis-segregation and anaphase bridges [24].
In mammals, however Ankle1 functions may be highly
redundant, as Ankle1 knockout mice and cells are
normal and did not show an impaired DNA damage
response [29].
The mammalian genome contains two genes encoding
proteins with a GIY-YIG nuclease domain, Ankle1 [22]
and Slx1, encoding Slx1 resolvase [30, 31]. Resolvases
are DNA-structure specific nucleases that process and
cleave Holliday junctions (HJ) [32–34]. HJs are inter-
mediate structures of covalently linked homologous
chromosomes during meiosis or of sister chromatids
during homologous recombination-mediated double
strand break (DSB) repair [35, 36]. HJs need to be elimi-
nated before the end of mitosis or meiosis to assure
proper chromosome segregation and to preserve genome
stability. Homologous recombination followed by HJ
resolution can result either in crossover (CO) events that
are obligatory at a certain frequency in meiotic cells to
allow exchange of genomic information, or non-
crossover (NCO) events, which are preferred in mitotic
cells because they avoid the loss of heterozygosity, a high
risk factor for the development of cancer [37, 38]. Two
major mechanisms are responsible for HJ processing in
mitotic cells: the preferred dissolution by the so-called
Bloom helicase BTR (BLM-TOPIIIα-RMI1-RMI2) com-
plex that results in NCOs [39], and the resolution of HJs
by structure specific endonucleases, such as the Slx4 com-
plex (Mus81-Eme1-Slx1-Slx4) or the canonical HJ resol-
vase Gen1, that can lead to COs and NCOs [34, 40–42].
Because dissolution is favored over resolution in mitosis,
the actions of resolvases are strictly regulated in a spatio-
temporal manner [38, 43]. In human cells, Eme1, a
subunit of the Slx4 complex is phosphorylated in prome-
taphase to stimulate interactions and activation of the
Mus81-Eme1-Slx1-Slx4 complex [38]. This ensures that
resolvases eliminate only HJs, which were not processed
by the BTR complex in S and G2 phase. The activity of
the human Gen1 resolvase is restricted to mitosis by nu-
clear exclusion during interphase through a leucine-rich
nuclear export signal (NES) [43]. Based on the evidence of
unprocessed chromatin structures in C. elegans lem-3 mu-
tants and the presence of a GIY-YIG nuclease domain in
Ankle1, we hypothesized that Ankle1 may also function in
DNA damage repair, probably redundantly with other nu-
cleases, and its nucleo-cytoplasmic shuttling and cellular
localization may be tightly controlled during the cell cycle
and upon DNA damage. Hence, we wanted to identify the
domains and motifs in Ankle1 involved in its nucleo-
cytoplasmic shuttling and test whether DNA damage may
alter Ankle1’s cellular localization. We identified one ca-
nonical nuclear localization sequence (NLS) and one nu-
clear export sequence (NES) in Ankle1 that mediate its
translocation into and out of the nucleus, respectively.
However, no changes in shuttling and/or cellular
localization were found upon induction of DNA damage
or during the cell cycle.
Results
Nucleocytoplasmic shuttling of Ankle1 is mediated by
active transport mechanisms
In a previous study, we showed that Ankle1 is pri-
marily localized in the cytoplasm in HeLa and B-cell
derived RAMOS cell lines, but it accumulated in the
nucleus upon inhibition of nuclear export by leptomy-
cin [22, 44]. This suggested that Ankle1 shuttles be-
tween the cytoplasm and the nucleus. In this study,
we wanted to identify the domains in Ankle1 that
mediate its shuttling, and test, whether nucleo-
cytoplasmic shuttling of Ankle1 and its cellular
localization change upon DNA damage or during the
cell cycle. Therefore we expressed Ankle1 in osteosar-
coma U2OS cells, which have intact pRb and p53
pathways [45] and have frequently been used in stud-
ies investigating DNA damage repair pathways, in-
cluding resolvase-mediated repair [46–48].
In agreement with previous studies [22], Ankle1 ec-
topically expressed in U2OS cells localizes predomin-
antly in the cytoplasm and accumulates in the
nucleus upon pharmacological inhibition of the
CRM1-dependent nuclear export using the drug lep-
tomycin B (Fig. 1). In silico analysis of the Ankle1
primary sequence predicted the existence of at least
two nuclear localization sequences (NLS) and two
nuclear export signals (NES) (Fig. 1a), suggesting that
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shuttling of Ankle1 may be mediated by active nu-
clear import and export pathways.
In order to get a first hint whether any of the NLSs
and NESs are responsible for nucleo-cytoplasmic shut-
tling of Ankle1, we generated a series of truncated
Ankle1 constructs C-terminally fused to green fluores-
cence protein (GFP), and tested their subcellular
localization by confocal fluorescence microscopy. Using
this approach, we also wanted to test whether specific
protein domains other than transport signal sequences
influence Ankle1 localization. These include the ankyrin
repeats, well known protein interaction domains found
in many proteins [49, 50], the LEM domain, known
to mediate binding to chromatin via Barrier-to-
Autointegration factor (BAF) [14, 16, 51], and the
GIY-YIG domain, mediating nuclease activity [25]
(Fig. 1a). Ankle11–420, which lacks the C-terminal do-
main including the GIY-YIG motif and the two NLSs,
is effectively exported to the cytoplasm in both U2OS
and HeLa cells (Fig. 2). Additional deletion of the
LEM domain (Ankle11–354) did not alter the predom-
inant cytoplasmic localization of the construct in the
absence of leptomycin B. Hence we concluded that
neither the LEM domain nor the GIY-YIG domain
affect nuclear export (Fig. 2). The construct lacking the N-
terminal ankyrin repeats (including the predicted NES1
sequence) (Ankle1158–615) was efficiently excluded from
the nucleus in both U2OS and HeLa cells, indicating that
neither ankyrin repeats nor NES1 are essential for nuclear
export and/or cytoplasmic localization. In agreement with
this hypothesis, Ankle11–141 containing only NES1 was
not efficiently exported from the nucleus (Fig. 2b), while
both Ankle1158–420 and Ankle1158–354 encompassing the
central region containing only NES2 with or without the
LEM domain, respectively, localize exclusively to the cyto-
plasm (Fig. 2a). In addition, leptomycin B-mediated inhib-
ition of nuclear export caused efficient accumulation of
most constructs in the nucleus, suggesting that a region
including NES2 is sufficient for Ankle1 export. Altogether
these data suggest that Ankle1 is actively exported from
the nucleus predominantly through a NES2-mediated
mechanism. We assume that also its nuclear import is
mediated by an active NLS-mediated mechanism based
on the following observations. First, Ankle1158–615, con-
taining NES2 and both predicted import sequences NLS1
and NLS2 efficiently accumulates in the nucleus in the
presence of leptomycin B like the wild-type protein,


























Fig. 1 Ankle1 shuttles between nucleus and cytoplasm. a Schematic representation of Ankle1’s domain organization depicting predicted ankyrin
repeats, the LEM domain and a GIY-YIG nuclease domain. Putative nuclear export sequences (NES1, NES2) and nuclear localization sequences
(NLS1, NLS2), identified in silico are indicated. b Immuno-fluorescence analysis of ectopic Ankle1-V5 in U2OS cells without or following a 3 h
treatment with 50 nM leptomycin B, an inhibitor of CRM1-mediated export. Cells were stained with antibodies to V5, and DNA with DAPI. Scale
bar: 10 μm
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efficient nuclear translocation by passive diffusion through
nuclear pores [52]. Secondly, a 51 kDa large construct
containing the nuclear localization signal (NLS2) is exclu-
sively targeted to the nucleus (Fig. 2, Ankle1412–615), des-
pite its size would allow some passive diffusion out of the
nucleus. We therefore conclude that Ankle1 is shuttling
between the nucleus and the cytoplasm through active im-
port and export mechanisms, but its nuclear export seems
to overrule nuclear transport, as at steady-state, Ankle1 is
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Fig. 2 Localization of Ankle1 fragments containing different domains and export and import signals. Localization of GFP-tagged Ankle1 truncation
constructs ectopically expressed in U2OS (a) and HeLa (b) cells was determined by confocal fluorescence microscopy. Molecular weights and
schematic representations of domain organization of respective truncation protein constructs are indicated. Cells were fixed after 3 h of mock or
leptomycin B treatment. DNA was counterstained with DAPI. Scale bar: 10 μm
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Mutation analyses identify NES2 and NLS2 as major
transport-mediating signals
Our experiments using truncated Ankle1 constructs in-
dicated that NLS2 and NES2 are the predominant regu-
lators of active import and export, respectively. To test
whether this hypothesis holds true also in the context of
the full length protein, we analyzed the localization of
full length Ankle1 constructs carrying point mutations
at conserved residues within the nuclear transport se-
quences NES1, NES2, NLS1 and NLS2 (Fig. 3). Further-
more, in order to avoid potential effects of the bulky
GFP tag we used the smaller V5-tag instead. Mutation of
NES1 (Ankle1-NES1mut) caused only a subtle impair-
ment of nuclear export (Fig. 3a), as indicated by the
minor increase in the ratio of nucleoplasmic over cyto-
plasmic signal intensities of the mutant compared to
wild-type control (Fig. 3c). In contrast, substitution of
conserved leucine residues within the NES2 impaired
nuclear export of Ankle1 and caused a significant in-
crease in the steady-state fraction of the protein in the
nucleus compared to the control (Fig. 3b, c). Given that
nuclear export is predominant in defining the steady
Fig. 3 Mutation analyses identify NES2 and NLS2 as the predominant sequences controlling nucleo-cytoplasmic shuttling of Ankle1. a, b, d, e U2OS
cells were transiently transfected with Ankle1-V5 carrying point mutations in NLS or NES sequences and either mock-treated or treated
with leptomycin B for 3 h and processed for confocal immunofluorescence analyses using antibodies to V5 and DAPI to detect DNA.
Scale bars: 10 μm. c Mean fluorescence intensities in nuclei and cytoplasm of cells expressing wild-type Ankle1-V5, Ankle1-NES1mut-V5 or
Ankle1-NES2mut-V5 were measured in original unprocessed digital images prior to contrast/brightness adjustment and nucleus to cytoplasm
signal ratios were calculated. Data were obtained from three independent experiments and analyzed using Student’s t-test. Ankle1-NES1,
P = 0.002; Ankle1-NES2, P = 5.4E-21; n = 50; 15–17 cells each from three independent experiments
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state localization of Ankle1, it was only possible to
examine the consequences of NLS1 and NLS2 mutations
following leptomycin B-mediated inhibition of nuclear
export. Mutation of the positively charged residues
within NLS1 did not affect Ankle1’s accumulation in the
nucleus (Fig. 3d) under this condition, whereas mutation
of NLS2 impaired nuclear import nearly completely
(Fig. 3e). In summary, we concluded that NES2 and
NLS2 are the predominant signals mediating active
nucleo-cytoplasmic shuttling of Ankle1.
In support of this, we also show by fusing wild-type
and mutated versions of NLS2 and NES2 sequences to
GFP, that the wild-type, but not mutated sequences are
sufficient to mediate active transport of heterologous
proteins. Wild-type NES2-GFP, but not the mutated
construct was efficiently excluded from the nucleus
(Fig. 4a, b). Wild-type NLS2 sequence mediated efficient
accumulation of the fusion construct in the nucleus,
whereas the mutated version was distributed throughout
the cell (Fig. 4c, d).
Overall we show that Ankle1 localization is deter-
mined predominantly by the activity of two transport
signals, a nuclear export signal in the middle of the poly-
peptide and a C-terminal nuclear localization signal.
Ankle1 does not change localization upon DNA damage
and during mitosis
It was previously reported that a C. elegans mutant for
lem-3, the worm ortholog of mammalian Ankle1, is
hypersensitive to DNA damage-causing agents [24].
Furthermore, Ankle1 may be functionally related to
Slx1, the only other known GIY-YIG-type endonuclease
encoded in the mammalian genome, which is involved
in homologous recombination-mediated repair of DNA
double strand breaks in a cell cycle-regulated manner.
Thus, we speculated that Ankle1 may have a similar
function in DNA damage repair and set out to test
whether Ankle1 may transiently accumulate in the nu-
cleus and/or on chromatin upon induction of the DNA
damage response signaling or during the cell cycle.
However, as long-term expression of wild-type Ankle1
causes cell death (data not shown), we generated a stable
U2OS cell line ectopically expressing an endonuclease-
































































































Fig. 4 NES2 and NLS2 are functional export and import signals in heterologous reporter constructs. U2OS cells were transiently transfected with
GFP constructs fused to the wild-type or mutated versions of NES2 or NLS2, fixed and prepared for fluorescence microscopy (a, c). Representative
images of at least three independent experiments are shown. Scale bars: 10 μm. b, d Mean fluorescence intensities in nuclei and cytoplasm of
GFP-NES2wt, GFP-NES2mut (b), GFP-NLS2wt or GFP-NLS2mut (d) transfected cells were measured in original unprocessed digital images prior to
contrast/brightness adjustment, and nucleus to cytoplasm signal ratios were calculated. Data were obtained from three independent experiments
and analyses were done using Student’s t-test. GFP-NES2mut, P = 7.9E-30; GFP-NLS2mut, P = 9.1E-18; n = 43; 13–15 cells each from three
independent experiments
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Ankle1 dynamics during the cell cycle and upon induc-
tion of DNA damage. The catalytically dead Ankle1
mutant shuttles between the cytoplasm and the nucleo-
plasm and has a predominant cytoplasmic localization at
steady state like the wild-type protein (Additional file 1:
Figure S1A). However, unlike for wild-type Ankle1,
leptomycin B-dependent accumulation of the Ankle1
mutant in the nucleus did not induce DNA damage
(Additional file 1: Figure S1B).
To investigate potential changes in Ankle1 localization
upon induced DNA damage, we treated cells with vari-
ous chemical compounds, which cause different types of
DNA damage and elicite different DNA repair pathways:
bleomycin, a radio-mimetic drug inducing double strand
breaks and mitomycin C, creating DNA crosslinks,
which both are mainly repaired by non homologous end
joining (NHEJ) or HR, and UV irradiation that triggers
the nucleotide excision repair (NER) pathway (reviewed
in [53]). Drugs were applied for short time periods at
high concentration to study immediate DNA damage re-
sponse (Fig. 5a) or at low dosage over a prolonged time
period to cause constant DNA damage to allow activa-
tion of downstream DNA damage response signaling
events (Fig. 5b). However, although the different types of
treatments induced DNA damage response, as shown by
the upregulation of the γH2A.X marker compared to
untreated control samples (Additional file 2: Figure S2),
we did not observe a (transient) change in the
localization of Ankle1 nuclease-dead mutant (Fig. 5 and
data not shown). Hence, Ankle1 localization may not be
affected upon induction of DNA damage response
signaling, or the catalytically dead mutant is unable to
respond to induction of DNA damage signaling.
Next we tested whether Ankle1, like the mammalian
resolvases, may serve in DNA repair pathways during
late G2 or M phase of the cell cycle, as shown for the
resolvases Mus81, Slx1 and Gen1 [42, 43]. We first ana-
lyzed Ankle1 localization throughout the cell cycle and
focused in particular on the potential association of
Ankle1 with condensed chromosomes during mitosis.
Ankle1 is uniformly distributed throughout the cyto-
plasm in different stages of mitosis, both in fixed
(Additional file 3: Figure S3) and live cells with (Additional
file 4: Movie S1) or without DNA damage induction (not
shown). Unrepaired DNA damage and persistent HJs were
shown to lead to defects in chromosomal segregation dur-
ing anaphase [47], visible as small DNA fibers connecting
separated chromatids (so-called anaphase bridges). Resol-
vases are known to be activated upon such mitotic defects
and to localize to these anaphase bridges [54] in order to
resolve HJs and to allow mitotic progression without
chromosomal mis-segregation. We tested whether Ankle1
shows a similar re-localization to anaphase bridges follow-
ing treatment of cells with the replication inhibitor hy-
droxyurea to increase the frequency of such mitotic
defects. Screening mitotic figures in three independent ex-
periments did not reveal re-localization and/or accumula-
tion of Ankle1-dead mutants to anaphase bridges under
the given experimental setup (Fig. 6, arrows).
Discussion
In this study we show that Ankle1 endonuclease shuttles
between the cytoplasm and the nucleus by an active
NLS-mediated nuclear import and a NES-mediated
nuclear export, despite its predominant steady-state
localization in the cytoplasm. Using various Ankle1 dele-
tion constructs and full length Ankle1 with mutated,
non-functional transport signals, we find that nucleo-
cytoplasmic shuttling is predominantly achieved by the























Fig. 5 Ankle1 does not relocalize to the nucleus in response to DNA damage. U2OS cells stably expressing a catalytically inactive GFP-Ankle version
were treated with the DNA damaging agents bleomycin or mitomycin C for 4 h or 48 h using high and low dosages, respectively: 3 μg/mL bleomycin,
1 μg/mL mitomycin C for 4 h (a), 1 μg/mL bleomycin or 0.5 μg/mL mitomycin C for 48 h (b). Fixed cells were imaged using confocal microscopy and
representative images of at least three independent experiments are shown. Scale bars: 10 μm
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sequence [55] and a canonical rev-type NES sequence
[56] in the central region of Ankle1 polypeptide. As
Ankle1 efficiently accumulates in the nucleus upon
treatment with leptomycin B, a specific inhibitor of
CRM1 [57], Ankle1 is likely excluded from the nucleo-
plasm via a CRM1-dependent nuclear export. In silico
analysis predicted two potential nuclear export se-
quences fitting the highly conserved leucine-rich NES
sequence motif (LxxxLxxLxL, reviewed in [58]), one lo-
cated within the ankyrin repeats of Ankle1, the other in
the central region between the ankyrin repeats and the
LEM domain. Experimental testing showed that only the
latter was sufficient to mediate efficient nuclear export
of tested Ankle1 constructs (Figs. 2 and 4a, b). Similarly,
among the two predicted canonical monopartite NLSs
present in Ankle1 polypeptide, NLS2 at the very C-
terminus was found to mediate nuclear import. Several
observations speak in favor of an active NLS- and NES-
mediated transport of Ankle1, rather than a so-called
“piggy-back” mechanism in which Ankle1 is co-
transported with other proteins: First, wild-type Ankle1
but not Ankle1 mutants with a mutated nonfunctional
NES2 sequence were exported from the nucleus (Fig. 3b).
Second, Ankle1 mutants with a mutated nonfunctional
NLS2 sequence, unlike wild-type protein, were not
imported into the nucleus following leptomycin B treat-
ment (Fig. 3e). Third, both NLS2 and NES2 sequences
were able to mediate effective import and export, re-
spectively of a heterologous protein (Fig. 4).
Despite the presence of an active NLS sequence,
Ankle1’s steady state localization is predominantly cyto-
plasmic. In fact we were unable to detect any signal
above background in the nucleus by fluorescence mi-
croscopy. This observation raises the question, whether
additional factors may be involved favoring nuclear ex-
port over import or whether the predominant cytoplas-
mic localization is merely a consequence of a tightly
regulated balance between import and export rates. Po-
tential additional mechanisms involved in the regulation
of Ankle1 nucleo-cytoplasmic shuttling may involve
posttranslational modifications of Ankle1 or specific re-
tention in the cytoplasm by interaction with cytoskeletal
components, but currently there is no evidence for any
of these pathways being involved.
What may be the physiological relevance of nucleo-
cytoplasmic shuttling of Ankle1? Constant shuttling of
Ankle1 across the nuclear envelope, while primarily lo-
calizing in the cytoplasm may prevent accidental damage
in the genome caused by Ankle1’s endonuclease activity.
This hypothesis is supported by previous findings show-
ing that leptomycin B-mediated accumulation of Ankle1
in the nucleus causes DNA cleavage and cell death [22].
This hypothesis also predicts that the localization of
Ankle1 has to be regulated in a tightly controlled man-
ner dependent on DNA damage and/or the cell cycle as
shown for other nucleases:
DNAseI, a nuclease involved in apoptosis, is excluded
from the nucleus by association with cytoplasmic actin,
and association is stabilized by cofilin and disrupted by
N-gelsolin [59].
A tight regulation of nucleases was also reported for
HJ-processing resolvases, including Slx1, the only other
GIY-YIG domain-containing protein besides Ankle1 in
the human genome [30, 31]. Dissolution of HJs by the
BTR complex is the preferred mechanism in mitotic
cells, because it avoids CO formation [39], but HJs,
which could not be processed or escaped the BTR
complex-mediated repair can be resolved by one of the
three structure specific endonucleases: Slx1-Slx4,
Mus81-Eme1, or Gen1. In order to allow the pre-
ferred processing of HJs by BTR and use resolvases
only as a backup mechanism in G2 and M-phase of
the cell cycle, resolvase activity is tightly regulated
throughout the cell cycle. Slx1 is active only in a
complex with Slx4. Slx1 forms homodimers in G1
and S-phase of the cell cycle [60], and formation of
the active Slx4 complex (Mus81-Eme1-Slx1-Slx4) is
only promoted in prometaphase by phosphorylation
of Eme1 by cyclin dependent kinases (CDKs) [38].
Gen1 is regulated at the level of nuclear exclusion via








Fig. 6 Ankle1 does not accumulate on mitotic DNA bridges induced
by hydroxyurea treatment. U2OS cells stably overexpressing inactive
GFP-Ankle1 were grown in the presence of 100 μM hydroxyurea for
18 h. Cells were fixed and processed for confocal fluorescence
microscopy. Representative image out of at least 20 mitotic cells
from three independent experiments is shown. Arrows show DAPI
stained DNA bridges. Scale bar: 5 μm
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breakdown of the nuclear envelope during mitosis al-
lows Gen1 to access unresolved DNA bridges.
Based on these recently reported findings on the
regulation of resolvases we tested whether Ankle1
localization may be changed transiently upon inducing
DNA damage or during the cell cycle. However neither
long-term treatment at low doses nor short treatments
with higher doses of mitomycin C, UV-C and bleomycin
changed Ankle1 localization. Similarly, Ankle1 did not
change its localization during the cell cycle and did not
associate with anaphase bridges [47, 54] in mitotic cells
treated with hydroxyurea. One caveat of these studies is
that we had to use a catalytically inactive Ankle1 mutant
containing mutations in its GIY-YIG domain, as the
wild-type protein causes cell death and precluded cell
cycle dependent analyses. As the catalytically dead mu-
tant showed the same nucleo-cytoplasmic shuttling and
steady state cytoplasmic localization, we consider it un-
likely that the mutation in the GIY-YIG motive affects
its cellular localization. Therefore, we concluded that
Ankle1 localization is neither affected by activated DNA
damage response signaling nor cell cycle stages in U2OS
cells. Alternatively the high redundancy of HJ processing
pathways may obstruct the analysis of specific Ankle1
functions in HJ processing under these conditions.
Although data obtained in C. elegans [24] and recent
reports on a potential linkage of single nucleotide poly-
morphisms in the human Ankle1 gene with an increased
risk for certain cancers [61, 62] are consistent with a
function of Ankle1 in DNA damage response pathways,
we cannot exclude that it is involved in other cellular
processes. In this study, we elucidated one level in the
regulation of Ankle1 localization by identifying active
NLS and NES sequences.
Conclusions
This study identifies a centrally located rev-type CRM1-
dependent NES in the Ankle1 polypeptide and a C-
terminal canonical mono-partite NLS, which together
mediate shuttling of Ankle1 between the cytoplasm and
the nucleus and maintain a predominantly cytoplasmic
localization at steady state. Induction of DNA damage
response signaling did not affect cellular localization or
chromatin association of Ankle1 leaving it unclear, if
and how Ankle1 localization may be regulated upon
induction of DNA damage response signaling.
Methods
Cell culture and transfection
U2OS and HeLa cells were cultivated in Dulbecco’s modi-
fied Eagle’s medium (DMEM, PAA, Pasching, Austria)
supplemented with 10 % fetal calf serum (Invitrogen,
Carlsbad, CA), 100 U/mL penicillin, 100 μg/mL strepto-
mycin and 2 mM L-glutamine at 37 °C and 8.5 % CO2.
Transient transfections were carried out using the Nano-
fectin kit as stated in the manufacturer’s instructions
(PAA). Inhibition of CRM1-dependent nuclear export was
performed using 10 ng/mL leptomycin B (Enzo Life
Sciences, Lausen, Switzerland) for three hours. A stable
U2OS cell line expressing catalytically dead Ankle1 mu-
tant was generated by transfection of peGFP-Ankle1mut
followed by antibiotic selection (200 μg/mL G418) and
single cell clone expansion.
Plasmids and cloning
Site directed PCR mutagenesis was performed following
the manufacturer’s protocol (Stratagene, Santa Clara,
CA) by amplification of pEntry-Ankle1 [22] using
primers containing the desired point mutations and veri-
fied by sequencing. Primers are listed in Table 1. Subse-
quently, the obtained Ankle1 mutants were shuttled via
Gateway cloning (Invitrogen) into a Gateway-compatible
pTracerB plasmid [22].
GFP-tagged Ankle1 truncation constructs were gener-
ated by amplifying the DNA sequence encoding amino
acids 1–141, 158–615, 158–420, 158–354, 1–354, 1–420
and 412–615 by PCR. The oligos used for PCR (see
Table 1) contained a SalI restriction site within the for-
ward and a XbaI restriction site in the reverse primer,
the generated PCR products were cut and ligated into
Table 1 Primer sequences used for site directed PCR
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the SalI/XbaI sites of peGFP-C1 (Clonetech, Mountain
View, CA).
GFP-NES2wt and GFP-NES2mut fusion constructs
were created by the PCR amplification of pEntry-
Ankle1-NES2wt or pEntry-Ankle1-NES2mut (amino
acids 246–319) (for primers see Table 1) and cloned into
peGFP-C1 vector using EcoRI and SalI restriction sites.
GFP-NLS2wt and GFP-NLS2mut were created using the
same restriction sites after amplification of the fragment
(amino acids 561–603) from the respective pEntry-
Ankle1-NLS2wt or pEntry-Ankle1-NLS2mut plasmids.
Catalytically dead GFP-Ankle1mut was generated by
PCR-based introduction of point mutations within the
GIY-YIG motif, replacing GIY by AAA using primers as
shown in Table 1.
Immunofluorescence microscopy and image analysis
Cells were grown on glass coverslips or seeded onto
Ibidi-treat microscopy slides for live-cell imaging. Cells
on coverslips were washed twice with PBS, fixed in PBS
containing 4 % paraformaldehyde for 10 min and perme-
abilized with 0.5 % Triton-X-100 in PBS for 5 min. Fixed
cells were rinsed three times with PBS and blocked with
3 % BSA in PBS for at least 1 h. Cells transfected with
Ankle1-V5 constructs were incubated with a mouse
anti-V5 primary antibody (Invitrogen) diluted 1:200 in
blocking solution for 45 min at room temperature,
washed three times with PBS and probed with a fluores-
cently labeled secondary antibody (DyLight 650, Thermo
Scientific, Waltham, MA) as described for the primary
antibody. All samples were counterstained with 100 ng/mL
DAPI (Sigma, Munich, Germany) for 5 min and mounted
in Mowiol (Fluka, Buchs, Switzerland).
Images were acquired on a confocal laser scanning
microscope (LSM 710, Carl Zeiss, Jena, Germany) using
a 63x/1.4 NA Plan-Apochromat oil immersion objective.
Live-cell imaging was performed on a spinning disc
microscope, using a 63x/1.4 NA Plan Apochromat DIC
oil immersion objective (Visitron Systems, Germany).
Mean fluorescence intensities were measured and
quantified in ImageJ (NIH, Bethesda, MD) using a short
script (“macro”) that creates a mask of the nucleus based
on the DAPI stain and measures fluorescence intensity
within this area in the V5 or GFP channel. Fluorescence
intensity in the cytoplasm was calculated by scanning
the mask of the whole cell (as stained in the V5 or GFP
channel), from which we subtracted fluorescence
intensity measured in the nucleus. Quantification of
fluorescence intensities was done using the original, un-
processed raw data (without contrast and brightness
adjustments). Digital images for production of printable
figures were adjusted for brightness and contrast and
exported using the LSM Image-Browser (Zeiss) and
Adobe Illustrator (Adobe Systems, San Jose, CA).
Additional files
Additional file 1: Figure S1. Catalytically dead Ankle1 mutant shuttles
like wild-type Ankle1 but does not induce DNA damage response. (A)
U2OS cells stably expressing GFP-Ankle1mut (GIY-YIG to GIY-AAA) were
imaged using confocal microscopy without or after 3 h leptomycin B
treatment. (B) U2OS cells were transiently transfected with Ankle1wt-V5
or Ankle1mut-V5 (GIY-YIG to GIY-AAA). Cells were analyzed by confocal
immunofluorescence microscopy following staining with antibodies to V5
and γH2A.X. Scale bars: 10 μm. (PDF 990 kb)
Additional file 2: Figure S2. DNA damage response is active in U2OS
cells stably overexpressing GFP-Ankle1mut. Cells were fixed and stained
for γH2A.X either untreated or after overnight treatment with bleomycin
(1 μg/mL), mitomycin C (0.5 μg/mL) or hydroxyurea (100 μM) and
imaged using confocal microscopy. Scale bar: 10 μm. (PDF 976 kb)
Additional file 3: Figure S3. Ankle1 does not accumulate on
condensed chromosomes during mitosis. U2OS cells stably expressing
GFP-Ankle1mut were fixed, stained with DAPI and imaged using a
LSM700 confocal microscope. Representative images of at least five cells
per mitotic phase from three independent experiments are shown. Scale
bar: 10 μm. (PDF 1788 kb)
Additional file 4: Movie S1. Ankle1 does not relocalize from the
cytoplasm upon treatment with mitomycin C. Living U2OS cells
expressing GFP-Ankle1mut were imaged for 22 h (upper left corner) in
the presence of 1 μg/ml mitomycin C on a spinning disc microscope.
Time interval between images is 7 min. (AVI 340222 kb)
Abbreviations
CO, crossover; DSB, double strand break; GFP, green fluorescence protein; HJ,
Holliday Junction; HR, homologous recombination; LEM, LAP-Emerin-MAN;
NCO, non-crossover; NES, nuclear export signal; NLS, nuclear localization
signal
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